Public Health Webinar Series on Blood Disorders- Bringing Science into Practice
Key Findings from Recent Investigator-Initiated Multicenter Trials in Pediatric Venous Thromboembolism Treatment and Prevention: Kids-DOTT (Duration of Therapy for Thrombosis) and COVAC-TP (COVID-19 Anticoagulation in Children – Thromboprophylaxis)
In this webinar, Drs. Goldenberg and Sochet will discuss key aspects of VTE in children, including incidence, risk factors, and outcomes, as well as critical knowledge gaps in optimal treatment and prevention. They will then summarize the design and findings of two recently published investigator-initiated clinical trials of VTE treatment (Kids-DOTT phase 3 multinational trial on duration of anticoagulation in patients younger than 21 years old with provoked VTE) and prevention (COVAC-TP, U.S. national phase 2 on pharmacological thromboprophylaxis in children hospitalized for COVID-19-related illness, including multisystem inflammatory syndrome in children). Lastly, they will outline key questions for future research.
This webinar is free and open to healthcare providers, pharmacists, and public health researchers who desire more information about venous thromboembolism.
For more information please contact Cynthia Sayers: [email protected].
